Skip to main content

Articles

Online First
Perspectives
A Call for Innovation: We Need to Go Off Road to Ensure Medication Adherence Amid COVID-19
Javier Gonzalez, PharmD
Read More
Perspectives
What Is Your IQ(VIA)?
David B. Nash, MD, MBA
Read More
Online First
Original Research, Practice Management
Budget Impact of Adaptive Abiraterone Therapy for Castration-Resistant Prostate Cancer
Neil T. Mason, MBA; Jason M. Burkett, CPA, MACC; Ryan S. Nelson, PharmD; Julio M. Pow-Sang, MD; Robert A. Gatenby, MD; Timothy Kubal, MD, MBA; John W. Peabody, MD, PhD; G. Douglas Letson, MD; Howard L. McLeod, PharmD; Jingsong Zhang, MD, PhD
Read More
Online First
Review Article, Original Research
Negative Consequences of the Widespread and Inappropriate Easy Access to Purchasing Prescription Medications on the Internet
Jack E. Fincham, PhD, RPh
Read More
Online First
Original Research
College Students’ Perceptions About Prescription Drug Misuse Among Peers
Chibuzo Iloabuchi, BPharm; Eiman Aboaziza, MD; Xiaohui Zhao, MS, PhD; J. Douglas Thornton, PhD, PharmD, BCPS; Nilanjana Dwibedi, BPharm, MBA, PhD
Stakeholder Perspective
Helping College Students Avoid Prescription Drug Misuse and Peer Pressure
Quang Nguyen, DO, FACP, FACE, FTOS
Read More
Lymphoma
ZUMA-12: Axicabtagene Ciloleucel Shows Substantial Benefit in High-Risk Large B-Cell Lymphoma
Chase Doyle
Read More
In the Literature, Oncology
Pembrolizumab Shows Long-Term Benefits in Metastatic Colorectal Cancer and MSI-H or dMMR
Read More
In the Literature, Gastroenterology, Oncology
Sitagliptin, DPP-4 Inhibitor, Reduces the Incidence of Acute GVHD After Stem-Cell Transplant
Read More
Lymphoma
Step-Up Glofitamab Dosing Induces High Response Rates in Relapsed or Refractory Non-Hodgkin Lymphoma
Chase Doyle
Read More
Momelotinib, a Novel JAK Inhibitor, Makes Inroads in Intermediate- or High-Risk Myelofibrosis
Phoebe Starr
Read More
Page 25 of 244
Results 241 - 250 of 2440